PET diagnostics in oncology: Examples from the practice;Beispiele aus der praxis: PET-diagnostika in der onkologie

Pharmazie in Unserer Zeit

Volumn 34, Issue 6, 2005, Pages 490-497

  Machulla, Hans Jürgen ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; MEMBRANE LIPID; RADIOPHARMACEUTICAL AGENT; TECHNETIUM 99M; DIAGNOSTIC AGENT;

ARTICLE; GLUCOSE METABOLISM; HUMAN; HYPOXIA; LIPOGENESIS; MEDICAL PRACTICE; ONCOLOGY; POSITRON EMISSION TOMOGRAPHY; PROTEIN SYNTHESIS; RADIODIAGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; REVIEW;

HUMANS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 28544451949     PISSN: 00483664     EISSN: None     Source Type: Journal    
DOI: 10.1002/pauz.200500147     Document Type: Article

References (28)

1. Ido, T., Wan, C.N., Fowler, J.S., Wolf, A.P.: Fluorination with F2. A convenient synthesis of 2-deoxy-2-fluoro-D-glucose. J. Org. Chem. 42 (1977), 2341-2342.
2. 18F]fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J. Nucl. Med. 27 (1986), 235-238.
3. Gambhir, S.S., Czernin, J., Schwimmer, J., Silverman, D.H.S., Coleman, R.E., Phelps, M.E.: A Tabulated Summary of the FDG PET Literature. J. Nucl. Med. 42 (2001), 1S-93S.
4. Shields, A.F., Grierson, J.R., Dohmen, B.M., Machulla, H.J., Stayanoff, J.C., Lawhorn-Crews, J.M., Obradovich, J.E., Muzik, O., Manger, T.J.: Imaging Proliferation In Vivo with [F-18] FLT and Positron Emission Tomography (PET). Nat. Med. 4 (1998) 1334-1336.
5. Machulla, H.J. (Ed.): Imaging of Hypoxia. (Developments in Nuclear Medicine 33), Kluwer Academic Publisher, Dordrecht (1999).
6. 18F]fluoromisonidazole uptake on oxygen delivery and tissue oxygenation in the porcine liver. Nucl. Med. Biol. 27 (2000), 693-700.
7. Piert, M., Machulla, H.J., Picchio, M., Reischl, G., Ziegler, S., Kumar, P., Wester, H.J., Beck, R., McEwan, A.J.B., Wiebe, L.I., Schwaiger, M.: Hypoxia-Specific Tumor Imaging with 18F-Fluoroazomycin Arabinoside. J. Nucl. Med. 46 (2005), 106-113.
8. 18F-Misonidazole-PET in non-small cell lung cancer and head-and-neck caner prior to radiotherapy. J. Nucl. Med. 46 (2005), 253-260.
9. Hara, T., Kosaka, N., Kondo, S., Kondo, T.: PET Imaging of Prostate Cancer Using Carbon-11-Choline. J. Nucl. Med. 39 (1998), 990-995.
10. 18F-labeled Choline as an Oncological Tracer for Positron Emission Tomography: Initial Findings in Prostate Cancer. Cancer Res. 61 (2000), 110-117.
11. 18F- Fluoroethycholine for Cancer Imaging with PET: Synthesis, Biochemistry, and Prostate Cancer Imaging. J. Nucl. Med. 43 (2002), 187-199.
12. Kotzerke, J., Prang, J., Neumaier, B., Volkmer, B., Guhlmann, A., Kleinschmidt, K., Hautmann, R., Reske, S.N.: Experience with carbon-11 choline positron emission tomography in prostate carcinoma. J. Nucl. Med. 27 (2000), 1415-1419.
13. 11C]choline PET for detection of metastases of prostate cancer. Nuklearmedizin 42 (2003), 25-30.
14. l1C-choline the most appropriate tracer for prostate cancer? For. Eur. J. Nucl. Med. Mol. Imaging 31 (2004), 753-756 .
15. l1C-choline the most appropriate tracer for prostate cancer? Against. Eur. J. Nucl. Med. Mol. Imaging 31 (2004), 756-759.
16. Yoshimoto, M., Waki, A., Obata, A., Furukawa, T., Yonekura, Y., Fujibayashi, Y.: Radiolabeled choline as a proliferation marker: comparison with radiolabeled acetate. Nucl. Med. Biol. 31 (2004): 859-865.
17. Yoshimoto, M., Waki, A., Yonekura, Y., Sadato, N., Murata, T., Omata, N., Takahashi, N., Welch, M.J., Fujibayashi, Y.: Characterization of acetate metabolism in tumor cells in relation to cell proliferation: Acetate metabolism in tumor cells. Nucl. Med. Biol. 28 (2001), 117-122.
18. Shreve, P., Chiao, P.C., Humes, H.D., Schwaiger, M., Gross, M.D.: Carbon-11-Acetate PET Imaging in Renal Disease. J. Nucl. Med. 36 (1995), 1595-1601.
19. 18F-FDG in prostate cancer patients. Eur. J. Nucl. Med. Mol. Imaging 30 (2003), 607-611.
20. 11C-Acetate PET Imaging of Prostate Cancer. J. Nucl. Med. 43 (2002), 181-186.
21. Hofmann, M., Maecke, H., Borner, R., Weckesser, E., Schoffski, P., Oei, L., Schumacher, J., Henze, M., Heppeler, A., Meyer, J., Knapp, H.: Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data. Eur. J. Nucl. Med. 28 (2001), 1751-1757.
22. 111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors. Mol. Imaging Biol. 5 (2003), 42-48.
23. 18F]fluoroethyl)-L-tyrosine in vitro and in vivo. J. Nucl. Med. 40 (1999), 1367-1373.
24. 18F-FDG. J. Nucl. Med. 44 (2003), 533-539.
25. Ishiwata, K., Kubota, K., Murakami, M., Kubota, R., Sasaki, T., Ishii, S., Senda, M.: Re-evaluation of amino acid PET studies: can the protein synthesis rates in brain and tumor tissues be measured in vivo? J. Nucl. Med. 34 (1993), 1936-1943.
26. Kim, S., Chung, J.K., Im, S.H., Jeong, J.M., Lee, D.S., Kim, D.G., Jung, H.W., Lee, M.C.: (11)C-methionine PET as a prognostic marker in patients with glioma: comparison with (18)F-FDG PET. Eur. J. Nucl. Med. Mol. Imaging 32 (2005), 52-59.
27. Coenen, H.H., Kling, P., Stöcklin, G.: Cerebral metabolism of L-[2-18F]fluorotyrosine, a new PET tracer of protein synthesis. J. Nucl. Med. 30 (1989), 1367-1372.
28. Pauleit, D., Floeth, F., Harnacher, K., Stoffels, G., Bauer, D., Coienen, H.H., Langen, K.J.: Der kombinierte Einsatz von FET PET und MRT verbessert die Diagnostik bei Gliomen. Nuklearmedizin 44 (2005), 49-68.